Researchers at AdventHealth are working to tackle a growing problem – the prevalence of undiagnosed type 1 diabetes (T1D) in its early stages, in particular among the state’s underserved and minority communities – to increase access to care.
While type 2 diabetes is more prevalent, type 1 is on the rise. Type 1 diabetes can cause diabetic ketoacidosis, a potentially deadly condition that is present in up to 60% of children at the time of diagnosis when not caught early via screening. Type 1 diabetes is associated with various acute and chronic complications, including early death.
“We have improved technology and treatments, including a new medication that can delay T1D clinical onset, and we can predict that T1D will occur,” said Anna Casu, MD, principal investigator on the study. “But the data tell us that people from ethnic and racial minority groups or people in disadvantaged communities tend to have less access to pre-clinical screening and advanced care. We are working to change that.”
Funded by the state of Florida, the project is known as Access to Clinical Care, Education and Screening for Underserved Children and Adults with Type 1 Diabetes (ACCESS-T1D). In addition to increasing screening and treatment access, researchers plan to establish a biobank, which will help them to identify new and better biomarkers of T1D.
“We will bring screening opportunities physically closer to those who are at high risk of T1D, reducing their burden and facilitating participation, especially of underserved and disadvantaged populations, who often cannot take time off their work or family commitments to take care of themselves,” said Dr. Casu, who herself has T1D.
Researchers are seeking participants who meet at least one of the following criteria:
- One or more first- or second-degree family members (siblings, parents, cousins, aunts, uncles, grandparents) diagnosed with type 1 diabetes;
- Have other autoimmune diseases such as but not limited to celiac disease, multiple sclerosis, rheumatoid arthritis or thyroid disease;
- Those diagnosed with other forms of diabetes but are suspected to have T1D and have been misdiagnosed.
An awareness campaign will soon be launched about the study and screening opportunities. People interested in participating can call Call407-303-7193, Call877-854-8475 or visit TRI-MD.org.
6 items. To interact with these items, press Control-Option-Shift-Right Arrow.
Final steel beam marks key step in AdventHealth Daytona Beach expansion
Local leaders, officials, and construction workers gathered today to commemorate a major milestone in the expansion underway at AdventHealth Daytona Beach: placing the final steel beam.
Orthopedic surgeon returns to AdventHealth
Dr. Jeffrey Keen, a board-certified orthopedic surgeon specializing in adult reconstruction, orthopedic surgery, robotic-assisted surgery, and sports medicine, has returned to AdventHealth Medical...
Hundreds of transplant patients and their families reunite with AdventHealth Transplant Institute caregivers
In recognition of National Donate Life Month, nearly 300 transplant patients and their families enjoyed AdventHealth’s 2025 transplant reunion.
Ashley and Jimmy celebrate life together after kidney donation
According to the National Kidney Foundation, more than 101,000 people are currently on the organ transplant list in need of a new kidney. However, only about 17,000 transplants happen each year —...
David Banks named president/CEO for AdventHealth
The AdventHealth Board of Directors has appointed David Banks as the organization’s new president/CEO, effective immediately.
More than 9,400 pounds of food distributed through new AdventHealth, United Way of Central Florida partnership
Leaders and volunteers from AdventHealth, United Way of Central Florida, Hands for the Homeless and the community worked together to distribute more than 9400 pounds of food to people in need.